Juan P de-Torres is an expert in Pulmonology at Clinica Universidad de Navarra (Spain). As of October 2026, ScienceLeadR ranks Juan P de-Torres in the top 1% of experts worldwide for Lung Diseases, Obstructive. Juan P de-Torres has authored 191 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 4 of them ongoing. SLR score: 676 (community average: 125). How the SLR is computed.

LeadR Profile

Juan P de-Torres Clinica Universidad de Navarra Spain
676 ScienceLeadR Reputation 676
Network Map

Pulmonology

Subspecialties: Oncology - Nutrition - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2029

Source: PubMed

Clinica Universidad de Navarra

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 191

Citations

Citations: 9 403 1st author: 43 Last author: 20 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prognostic Value of Plaque Burden Beyond Stenosis Severity in Patients with Stable Chest Pain Undergoing Coronary CT Angiography.
PMID 42930567 — constriction, pathologic, coronary artery disease, pain, angiography, sex, chest pain, computed tomography angiography
Med Sci (Basel)20260
Response.
PMID 42575661 — thoracic diseases
Chest20260
Response.
PMID 42575665 — thoracic diseases
Chest20260
Response: Considerations on Emphysema Assessment.
PMID 42108072 — thoracic neoplasms, emphysema
J Thorac Oncol20260
Comparison of Lung Cancer Screening Programs in Liver Transplant Recipients and the General Population.
PMID 42031619 — liver transplantation, lung, incidence, emphysema, neoplasms, liver, lung neoplasms, diagnosis, transplants, history, smoking
Arch Bronconeumol20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 6
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 1

By status:

Active not recruiting 3
Recruiting 3
Unknown 2
Completed 1
Terminated 1

By type:

Observational 6
Interventional 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 4
multicentric5to9 1
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD)
2025-520488-42-00 — safety, pulmonary disease, chronic obstructive, lung diseases, lung diseases, obstructive
Phase 2Active not recruiting2025
Monitoring Coughs for the Early Detection of Worsening COPD
NCT07212439 — intelligence, chronic disease, pulmonary disease, chronic obstructive, wearable electronic devices, lung diseases, artificial intelligence, cough, lung diseases, obstructive
N/ARecruiting2025
Clinical Validation of the Hyfe Cough Monitoring System
NCT05723159 — sleep, pulmonary disease, chronic obstructive, beds, environment, cough, chronic cough
N/AActive not recruiting2023
Exploring the anti aging effects of Metformin in COPD
2025-520972-24-00 — aging, pulmonary disease, chronic obstructive, lung diseases, lung diseases, obstructive, metformin
Phase 3Recruiting2026

LeadR Networks

Main global connection map